Cytokinetics, Incorporated
CYTK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$589,526 | -$526,244 | -$388,955 | -$215,314 |
| Dep. & Amort. | $9,531 | $11,892 | $5,814 | $2,276 |
| Deferred Tax | $0 | $0 | $0 | $2,844 |
| Stock-Based Comp. | $97,840 | $72,065 | $47,853 | $26,832 |
| Change in WC | $35,664 | $3,089 | -$24,704 | $8,456 |
| Other Non-Cash | $50,601 | $24,865 | $60,476 | $32,384 |
| Operating Cash Flow | -$395,890 | -$414,333 | -$299,516 | -$142,522 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,906 | -$1,416 | -$11,335 | -$48,872 |
| Net Acquisitions | $0 | $0 | $250,799 | $98,905 |
| Inv. Purchases | -$1,293,416 | -$635,211 | -$855,393 | -$525,042 |
| Inv. Sales/Matur. | $744,225 | $875,880 | $604,594 | $426,137 |
| Other Inv. Act. | $0 | $0 | -$250,799 | -$98,905 |
| Investing Cash Flow | -$553,097 | $239,253 | -$262,134 | -$147,777 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9,618 | -$858 | $334,661 | $0 |
| Stock Issued | $706,844 | $164,233 | $17,543 | $312,049 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $233,385 | $57,942 | $163,962 | $7,931 |
| Financing Cash Flow | $930,611 | $221,317 | $516,166 | $319,980 |
| Forex Effect | $209 | -$20 | $0 | $0 |
| Net Chg. in Cash | -$18,167 | $46,217 | -$45,484 | $29,681 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $113,399 | $67,182 | $112,666 | $82,985 |
| End Cash | $95,232 | $113,399 | $67,182 | $112,666 |
| Free Cash Flow | -$399,796 | -$415,749 | -$310,851 | -$191,394 |